Libby's H*O*P*E*

*Helping*Ovarian Cancer Survivors*Persevere Through*Education

Menu

Skip to content
  • Home
  • About
  • Mission
  • Warning Signs & Symptoms
  • Ovarian Cancer Overview
  • Prevention, Early Detection/Screening & Causes
  • Genetics
  • Types of Ovarian Cancer
  • Diagnosis & Staging
  • Treatment Overview
  • Surgery
  • Chemotherapy
  • Radiology & Radiation Therapy
  • Hormonal (Anti-Estrogen) Therapy
  • Biological (Immunotherapy & Vaccine) Therapy
  • Gene Therapy
  • Alternative & Complementary Therapy
  • Clinical Development
  • Clinical Trials
  • Coping
  • Survivorship
  • Ovarian Cancer Resources
  • Contact

Tag Archives: TRAIL

Researchers Are On The TRAIL To Killing Cancer With Genetically-Engineered Adult Stem Cells

Posted on May 21, 2009 by Paul Cacciatore

“Researchers in London have demonstrated the ability of adult stem cells from bone marrow (mesenchymal stem cells, or MSCs) to deliver a cancer-killing protein to tumors.  The genetically engineered stem cells are able to home to the cancer cells, both in culture and in mouse models, and deliver TNF-related apoptosis-inducing ligand (TRAIL), destroying the tumor cells while sparing normal cells. …”

Continue reading →

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Reddit (Opens in new window) Reddit
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email
Like Loading...
Posted in Medical Study Results, Meeting Highlights, Novel Therapies | Tagged adult stem cells, American Thoracic Society, Centre For Respiratory Research, Medical Research Council UK, mesenchymal stem cells, Michael Loebinger M.D. M.A., ovarian cancer, S.M. Janes M.D. Ph.D., TNF-related apoptosis-inducing ligand, TRAIL, University College of London, vector | Leave a comment
"Once you choose hope, anything is possible." -- Christopher Reeve

Categories

RSS Google Ovarian Cancer News

  • General Surgeons Can Help Prevent Ovarian Cancer - The American College of Surgeons
  • METTL3-mediated m6A modification of DNMT1 enhances ovarian cancer progression - Science | AAAS
  • Why has ovarian cancer screening eluded researchers for 4 decades? - Contemporary OB/GYN
  • Intact Resection and Surgical Staging of a Giant Right Ovarian Mucinous Borderline Tumor in a Patient With a Complex Surgical History: A Case Report - Cureus
  • New cell-collection device could improve early cancer detection - MIT News
  • Strange symptom and a "weird" referral led to a woman's Stage 4 cancer diagnosis: "Saved my life" - CBS News
  • Woman loses best friend to ovarian cancer, then receives same devastating diagnosis months later - Fox News
  • Ben Park: A Lasting Partnership Advancing the Future of Ovarian Cancer Research - Oncodaily
  • Bragg About It: Shannon Routh shares her powerful ovarian cancer story - WCNC
  • Notch ligand DLL1 shields ovarian cancer cells from ferroptosis, fueling cisplatin resistance - Bioengineer.org

Top Posts

  • 2009-2010 U.S. News & World Report Best U.S. Hospital Rankings
    2009-2010 U.S. News & World Report Best U.S. Hospital Rankings
  • About
    About
  • CNTO 328 Shows Promise For Ovarian Cancer In Small Clinical Trial, Say U.K. Scientists.
    CNTO 328 Shows Promise For Ovarian Cancer In Small Clinical Trial, Say U.K. Scientists.
  • Contact
    Contact
  • Ovarian Cancer Overview
    Ovarian Cancer Overview
  • In-Depth Review: The Cancer Genome Atlas Reports On Landmark Analysis of High-Grade Serous Ovarian Cancer
    In-Depth Review: The Cancer Genome Atlas Reports On Landmark Analysis of High-Grade Serous Ovarian Cancer
  • GPs Should Suspect Ovarian Cancer in All Women With Distended Abdomen, U.K. Researchers Warn
    GPs Should Suspect Ovarian Cancer in All Women With Distended Abdomen, U.K. Researchers Warn
  • Clinical Trials
    Clinical Trials
  • Mission
    Mission
  • PARP Inhibitor MK-4827 Shows Anti-Tumor Activity in First Human Clinical Study
    PARP Inhibitor MK-4827 Shows Anti-Tumor Activity in First Human Clinical Study

Archives

  • May 2015
  • September 2014
  • August 2014
  • May 2014
  • March 2014
  • August 2013
  • May 2013
  • February 2013
  • January 2013
  • July 2012
  • June 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008

Blog Stats

  • 514,969 Visitors
cancer blog

Enter your email address to subscribe to Libby's H*O*P*E* & receive notifications of new posts by email.

Join 341 other subscribers

 Subscribe in a reader

Click on the orange button above if you want to (i) add Libby's H*O*P*E*(tm) updates to a web-based or other reader, or (ii) embed a Libby's H*O*P*E* (tm) update widget on your desktop, website or blog.

Donate To Ovarian Cancer Research

OCRF is the largest U.S. private funding agency supporting ovarian cancer research. It is a not-for-profit, 501(c)(3) organization. Click on the OCRF logo above to make a donation.

Strategic Partners

Podcasts

Join Us In the Fight Against Ovarian Cancer

RSS New Ovarian Cancer Clinical Trials (Past 14 Days)

  • Study of Suvemcitug Plus Chemotherapy in Advanced High-Grade Serous Ovarian Cancer
  • A Project Assessing the Safety and Feasibility of Using Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Ovarian Cancer During Surgical Procedures
  • Peer Ambassador in Gyn Onc Trials
  • CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
  • Phase 1 Study of VT-101 in Advanced Ovarian Cancer
  • Methylation Profiling in Self-samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
  • A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid Tumors
  • A Study to Evaluate YF550 in Participants With Locally Advanced or Metastatic Solid Tumors.
  • Feasibility of the "One-Finger Technique" for Identifying the Upper Left Ureter During Para-Aortic Lymphadenectomy

RSS New Adult Solid Tumor Clinical Trials (Past 14 Days)

  • AI-Assisted Whole-Course Management for Medication Safety and Healthcare Burden in Advanced Solid Tumors: A Prospective Controlled Study
  • Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Head and Neck Squamous Cell Carcinoma With Suboptimal Response to Induction Immunochemotherapy
  • Testing the Anti-cancer Drug DSP-5336 (Enzomenib) in Prostate Cancer
  • A Study of the Safety and Effectiveness of a Compound Steep-Pulse Therapy Apparatus for Malignant Liver Tumors
  • A Study of QLS5314 Monotherapy in Participants With Advanced Solid Tumors
  • Phase 1/2, Open-label Study of ETX-929, a KRAS Inhibitor in Participants With Advanced Solid Tumors
  • Study Evaluating the Efficacy and Safety of BGB-B2033 in Participants With Advanced Hepatocellular Carcinoma
  • GFH375 Plus Cetuximab vs Investigator's Choice of Treatment in KRAS G12D-Mutant Refractory Metastatic Colorectal Cancer
  • A Study of SYH2051 in Combination With Irinotecan Hydrochloride Liposome Injection in Subjects With Advanced Solid Tumors
  • A Phase II Investigator-initiated Trial of Sacituzumab Tirumotecan Plus Pembrolizumab in Patients With Recurrent ovarIan Clear Cell Carcinoma Previously Treated With Platinum-based Chemotherapy(NCCH2407/MK014)

RSS Medical Studies

  • Assessment of genomic instability and homologous recombination repair in ovarian cancer using the Oncomine Comprehensive Assay Plus
  • Single-cell sequencing reveals immune networks and metabolic reprogramming in gynecological malignancies
  • Complete Surgical Resection of Rare Solitary Anterior Mediastinal Metastasis From Ovarian Clear Cell Carcinoma
  • Immunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations
  • Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation
  • PPP2R1A-mediated tumor-stromal adhesion as an unrecognized mechanism of immunosuppression
  • Decoding the phosphorylation landscape of ITPR3 across calcium signaling and regulatory networks in cancer
  • Regulatory Mechanisms and Therapeutic Targeting of Anoikis in the Metastasis of Gynecologic Malignancies
  • Expression, association with clinicopathological features and prognostic potential of FOXR2, mTOR, HIF-1α and PKM2 in high-grade serous carcinoma of the ovary
  • RPPH1 drives ovarian cancer cells proliferation via CDK9-c-Myc axis

Recent Comments

Prometey Bank's avatarPrometey Bank on World Ovarian Cancer Day: Toge…
mikaljhohnashly's avatarmikaljhohnashly on World Ovarian Cancer Day: Toge…
Jan C. Calthrop's avatarJan C. Calthrop on Lab-On-A-Chip: Veridex & M…
Paul Cacciatore's avatarPaul Cacciatore on About
Building a Team for… on About
Kathleen's avatarKathleen on About
Paul Cacciatore's avatarPaul Cacciatore on About
Liz's avatarLiz on About
Paul Cacciatore's avatarPaul Cacciatore on Dana Farber Webchat: The Lates…
Judith Marengere's avatarJudith Marengere on Dana Farber Webchat: The Lates…
Paul Cacciatore's avatarPaul Cacciatore on Dana Farber Webchat: The Lates…
Franca Pichini's avatarFranca Pichini on Dana Farber Webchat: The Lates…
painspeaks's avatarpainspeaks on SU2C Announces the Formation o…
marcy westerling's avatarmarcy westerling on SU2C Announces the Formation o…
anne's avataranne on Dana-Farber Oncologists Differ…

Blogroll

  • Site Meter Site Meter

Cancer Organizations

  • American Cancer Society
  • National Cancer Institute

Everyday Heroes

  • Are You There Cancer? It's Me, Jennie.
  • Bald Heads Are Sexy
  • Butterfly Ballet
  • Cancer Queen
  • Carrie's Journey
  • Chris Bledy
  • Diary of a Cancer Patient
  • I Want To Breathe
  • Janine's News
  • Journey Through Ovarian Cancer
  • Kristi & Brian: Living! With Cancer
  • Laurey Bikes
  • Life Cycle
  • livingly dying
  • Marcheline Bertrand Remembered
  • Meghan's Message
  • Monday Hearts For Madalene
  • My Journey With Teal
  • Nobody Has Ovarian Cancer
  • Out Shine Ovarian Cancer
  • OVACOM
  • Ovarian Cancer News
  • Ovarian Cancer?? pass the wine … now!
  • Scrambled Eggs, Surviving Ovarian Cancer
  • Shannon Miller Lifestyle
  • Still Smiling
  • Strong As Steele
  • Tenaciously Teal
  • The Carcinista
  • What? Me Worry?
  • Will There Be Cows In Heaven?
  • Women of Teal

Inspirational Cancer Advocates

  • Bald Is Beautiful
  • Bicycling For Ovarian Cancer (Craig Broeder)
  • Christine Druther
  • Fran Drescher
  • Imerman Angels
  • Jenn Sommermann: Training For a Cure
  • Jim Valvano
  • Laurey Masterton
  • Maddie Kullen
  • Mothers With Cancer
  • Randy Pausch
  • Sean Swarner
  • Standup2cancer
  • The Rock Band N.E.D.

Ovarian Cancer News Archive

  • Ovarian Cancer News Archive

Ovarian Cancer Organizations

  • National Breast & Ovarian Cancer Connection
  • National Ovarian Cancer Coalition
  • Ovarian Cancer National Alliance
  • Ovarian Cancer Research Fund
  • Ovations For the Cure

U.S. Treatment Centers

  • National Comprehensive Cancer Network Member Institutions
  • NCI-Designated Cancer Centers

Video Archive

  • Ovarian Cancer Video Library
Copyright 2008 - 2016 Paul Cacciatore, Libby's H*O*P*E*(TM), *Helping *Ovarian Cancer Survivors *Persevere Through *Education(TM), all rights reserved.
Paul Cacciatore

Create Your Badge
Site Meter
Blog at WordPress.com.
  • Subscribe Subscribed
    Libby's H*O*P*E*
    Join 216 other subscribers

    Have a WordPress.com account? Log in now.

  • Libby's H*O*P*E*
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar
%d